Abstract
Introduction
Hypertension (HT) is characterized by high blood pressure known to be a crucial risk factor for various disorders such as cardiovascular, neurological, and renal diseases. HT is the most frequent cause of death worldwide as well as in Turkey. It is a major threat to public health (1) (2) (3) (4) (5) . There is strong evidence that interactions of environmental and genetic factors contribute to the development of HT (6) (7) (8) (9) . The renin-angiotensin-aldosterone system (RAAS) is known to have an important role in blood pressure (BP) regulation by maintaining vascular tone and the water-sodium equilibrium. Angiotensinogen is hydrolyzed by renin to form the angiotensin-I that is then converted by angiotensin-converting enzyme (ACE) into the angiotensin-II (Ang-II) in RAAS pathways. The primary receptor of Ang-II is the Ang-II receptor type 1 (AGT1R). The expression pattern at both gene and protein levels of the molecular players mentioned above plays a crucial role in HT (10) (11) (12) . Various HT candidate genes that are related to renin angiotensin system (RAS) have been shown to contribute to BP regulation by different molecular mechanisms in the development of HT (10) . RAAS genes including ACE, AGT, and AGT1R are polymorphic genes. There are many studies investigating the relation between RAAS gene polymorphisms and the development and incidence of HT; however, conflicting results were also reported (3, 10, (12) (13) (14) (15) . It is possible that selection criteria of patients, environmental factors (e.g. geographic region), and ethnicity may contribute to the contradictory data from several studies about gene polymorphisms regarding HT (10, 12, 16) . In this study, we aimed to investigate if there is any relation between AGT (M235T), ACE (I/D), and AGT1R (A1166C) gene polymorphisms and HT among Turkish people in the region of Southeast Anatolia.
Materials and Methods

Selected Population
This study included 210 individuals consisting of 102 healthy controls who and whose relatives possess no cardiovascular diseases, and 108 patients with persistent and pathological high blood pressure who were admitted to the Cardiology Department of Adiyaman University Research and Application Hospital. In the present study, the confirmation by Adiyaman University Ethic Committee (date: 02.10.2013; number: 2013/10-1.1) and a written consent from each subject were provided after participants had been properly informed. All experiments were performed abided by the Declaration of Helsinki. Individuals who had aortic coarctation, previous cardiac surgery, valve stenosis greater than mild degree or regurgitation, complex congenital heart disease, chronic kidney disease, respiratory illness, acute infection, hepatic dysfunction or chronic inflammatory diseases were not included in the current study. The hypertensive patients who were receiving anti-hypertensive medication and the patients with essential hypertension were included in the study. There was no blood relation between the individuals included in the study. After a 5-minute rest in the sitting position for all individuals, blood pressure was measured three times on both upper limbs by using an automatic manometer (Omron M4 Plus, Omron Healthcare Europe, Hoofddorp, and Holland). The average value of the second and the third measurements were taken into account. The values exceeding 140 mmHg for systolic blood pressure (SBP) and 90 mmHg for diastolic blood pressure (DBP) were diagnosed as HT (17) .
Genotype determination
Genomic DNA was isolated from whole blood samples, which were collected in tubes containing EDTA, with a DNA isolation kit (Thermo Scientific, Lithuanian). Genotype determination was carried out by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Determination of polymorphisms in the ACE I/D (18), AGT1R A1166C (19) and AGT M235T (20) was performed in accordance with the previously described method, with minor modifications, as explained below. A 287-bp insertion or deletion in intron 16 of the ACE gene, which is called ACE I/D polymorphism, was determined with PCR in which forward primer 5-CTGCAGACCACTC-CCATCCTTTCT-3 and the reverse primer 5-GATGTGGCCATCACATTCGTCAGAT-3 were used. In a total volume of 50 μL, PCR was carried out, consisting of 10 pmol of each primer, 0.5 mM of each dNTP, 2 U Taq DNA polymerase, 1.5 mM MgCl2s, and 1 μL genomic DNA. PCR was carried out in a thermal cycler (Applied Bio systems Veriti); following an initial denaturation at 94 °C for 5 min, 35 rounds of thermo cycling consisting of denaturation at 94 °C for 1 min, annealing at 58 °C for 40 s, and extension at 72 °C for 1 min, then a final extension at 72 °C for 5 min. The amplification samples were run on an agarose gel (2%) and visualized by ultraviolet following ethidium bromide staining. The genotypes were determined to be homozygous deletion (DD) (190-bp), homozygous insertion (II) (490 bp), and the heterozygous (ID) insertion and deletion (490 bp/190 bp) (18, 21, 22) . For AGT M235T polymorphism, the 303 bp region of the angiotensinogen gene was amplified with PCR by using forward primer 5' GATGC-GCACAAGGTC CTGTC3' and reverse primer 5'CAG GGT GCT GTC CAC ACT GGA CCC C 3'. PCR was carried out in a total volume of 50 μL, consisting of 10 pmol of each primer, 0.5 mM of each dNTP, 2 U Taq DNA polymerase, 1.5 mM MgCl2, and 1 μL genomic DNA. Amplification was performed in a thermal cycler (Applied Biosystems Veriti); after an initial denaturation at 94 °C for 5 min, 35 rounds of thermocycling consisting of denaturation at 94 °C for 1 min, annealing at 57 °C for 40 s, and extension at 72 °C for 1 min, ending with a last extension at 72 °C for 5 min. Then the PCR products were digested using the PsyI, run on a 2% agarose gel, and visualized by ultraviolet transillumination following staining with ethidium bromide. Two fragments, the longer one consists of 279 bp and the shorter one contains 24 bp, appeared on the agarose gel after restriction digestion. The genotypes were determined to be homozygous MM (303-bp), homozygous TT (only a single 247-bp), and heterozygous MT (303-bp/247-bp) (20) . For AT1 A1166C polymorphism, the 410 bp region of the angiotensin II type 1 receptor (AT1R) gene was amplified with PCR by using forward-primer 5'-AGAAGCCTGCACCAT-GTTTTGAG -3'and reverse-primer-5'-CCT-GTTGCTCCTCTAACGATTTA -3'. PCR was carried out in a total volume of 50μL, consisting of 10 pmol of each primer, 0.5 mM of each dNTP, 2 U Taq DNA polymerase, 1.5 mM MgCl2 and 1 μL genomic DNA. PCR was carried out in a thermal cycler (Applied Bio systems Veriti); after an initial denaturation at 94 °C for 5 min, 35 rounds of thermocycling consisting of denaturation at 94 °C for 1 min, annealing at 62°C for 40 s and extension at 72 °C for 1 min, ending with a final extension at 72 °C for 5 min. Then the PCR products were digested using the Hind III, run on a 2% agarose gel, and visualized by ultraviolet transillumination after ethidium bromide staining. RFLP was ended up with the generation of 219 bp and 191 bp fragments. The genotypes were determined to be homozygous AA (410 bp), homozygous CC (219 bp and 191 bp) and heterozygous AC (410 bp, 219 bp, and 191 bp (19) .
Statistical analysis
In this study, the whole data was statistically analyzed using the packaged program IBM SPSS Statistics 2.0 software. The χ2 test was used to compare gender and genotype and al-lele frequencies of the ACE, AGT and AGT1R polymorphisms between HT patients and controls. The association between ACE, AGT, and AGT1R polymorphisms and HT was modeled through binary logistic regression analysis and odds ratio (OR) and 95% confidence interval (95%CI) were calculated to compare HT risk among genotypes. Such variables as age, height, weight, etc. were compared between groups with Mann-Whitney U Test for the non-normal variables and Student's t-Test for the normally distributed variables. Parameter values were compared between two groups with two independent sample t-and Mann Whitney-U tests. Additionally, to determine the normality, Shapiro-Wilk Test was used. p < 0.05 was accepted as statistically significant.
Results
The demographic and biochemical characteristics of the hypertensive patients and normotensive control groups are displayed in Table 1 . There were statistically significant differences between the control and patient groups with respect to systolic blood pressure (SBP) (p<0.001) and diastolic blood pressure (DBP) (p=0.05). However, there was no significant difference regarding other baseline characteristics (age, gender distribution, body mass index (BMI), high density lipoproteins (HDL), low density lipoproteins (LDL), triglycerides (TG), or diabetes mellitus (DM) (p>0.05). Demographic and biochemical characteristics of study groups are shown in Table 1 . 
ACE I/D:
Statistically significant differences were determined when control and patient groups were compared with respect to genotype distribution and allelic frequencies of ACE I/D polymorphisms (p<0.001). The genotype distributions and allele frequencies of the polymorphisms between hypertensive patients and normotensive controls are shown in Table 2 .
AGT M235T:
When patient and control groups were compared with respect to genotype distribution and allelic frequencies of AGT M235T polymorphisms, no significant difference was determined (p >0.05).
The genotype distributions and allele frequencies of the polymorphisms between hypertensive patients and normotensive controls are shown in Table 2 .
AGT1R A1166C:
When control and patient groups were compared in terms of genotype distribution and allelic frequencies of AGT1R A1166C polymorphisms, no significant difference was determined (p>0.05).
Haplotypes:
Haplotype distributions of ACE/AGT1R/AGT polymorphisms were compared between control and patient groups (p<0.001; Table 3 ). The haplotypes of the polymorphisms of hypertensive patients and normotensive controls were shown in Table 3 .
Discussion
The renin angiotensin system (RAS) takes an important part in the regulation of water-salt balance in the human body which is associated with HT. Many studies reported that there is a relationship between RAS gene polymorphisms, such as angiotensin converting enzyme (ACE I/D), angiotensinogen (AGT M235T), and the (3, 16, 20, 23) . However, there are also other studies which reflected contradictory results in this context. In the present study, we analyzed whether there is a correlation between polymorphisms of three RAAS genes and HT among affected Turkish people in the region of Southeast Anatolia. In our study, we found important differences between the normotensive control and hypertensive patient groups with respect to genotype distributions and allele frequencies of ACE I/D polymorphism (p<0.05). ACE I/D polymorphism was first identified by Rigat et al. in 1990 (24) . Presence or absence of 287 bp fragment in the 16th intron of the ACE gene gives rise to the polymorphism. Since it was identified, many studies have reported a correlation between the polymorphism and cardiovascular diseases, including HT and impaired serum ACE levels (25-27) Ramu et al. reported a correlation between ACE I/D polymorphism and increasing risk of essential hypertension (EH). Furthermore, they argued that interaction between polymorphisms in ACE and angiotensinogen genes contributes to development of EH (23) . In a study conducted by Cosenso Martin et al., the D allele (ID and DD genotypes) carriers had higher systolic blood pressure and 24-hour blood pressure compared to II genotype carriers, (p=0.036 and p=0.042, respectively). On the other hand, no difference was observed between the control and patient groups in terms of three genotypes (DD, ID, II) (p>0.05) (28). Jiang et al. assessed that D allele frequencies were higher in the HT group than in the control group (p<0.05) (10) . Contrary to our results, Gunes et al. did not find significant differences between ACE I/D genotype/allele frequencies and HT. In addition, they determined that the frequency of the D allele is higher than the I allele in Turkish patients with HT in the region of Central Anatolia (25) . These discrepancies in ACE I/D genotype distributions and allele frequencies may be due to regional differences in Turkey. Jiang et al. showed a significant difference in the distribution of ACE I/D between HT and control groups. They observed that DD genotype frequency was higher in HT patients than controls, and II genotypes were similar in both groups (10 (34) (35) (36) (37) (38) . In the present study, we did not observe any association between genotype distributions and allele frequencies of AGT M235T and AGT1R A1166C polymorphisms in the HT group compared to the control group. In line with our results, Yang et al. claimed that there is no correlation between genotype distributions and allele frequencies of AGT M235T and AGT1R A1166C polymorphisms in HT group when compared to control group (p=0.275 and p=0.184 respectively) (39) . In contrast, Niu S et al. found higher MM genotype frequencies of AGT M235T polymorphism in the HT patient group compared with the control group (13) . There are other studies which could not find a relationship between HT and AGT M235T or AGT1R A1166C polymorphisms (10, 40, 41) . In contrast, Niu W et al. found higher MM genotype frequencies of AGT M235T polymorphism in the patient group when compared with the control group (12) . In addition, Niu S et al. argued that there is an important relation between AGT M235T and AGT1R A1166C polymorphisms and EH (13) . In Turkish population, contrary to our results, Gunes et al. found significant difference between AGT1R A1166C polymorphism allele frequencies and HT. They determined that C allele frequency is higher in the HT group than in the control group (25) . In summary, the results of many similar studies performed with different populations are not in consistence with each other, likely due to strong ethnic and regional variations. Genetic variations in RAAS genes play an important role in the molecular etiology of EH. Therefore, alongside SNP studies, haplotype studies are also important in the identification of the association between RAAS genes and hypertension. In the haplotype analysis part of our study, the ratio of total haplotypes containing D allele were significantly lower in HT group. In line with that, this result is consistent with the significantly lower D allele frequency in the aforementioned hypertensive group.
Conclusion
In conclusion, we observed a significant association of ACE I/D polymorphism with HT in our study, and we showed that I allele can increase the risk of HT in the Turkish population of Southeast Anatolia. Although no correlation was found between independent AGT M235T and AGT1R A1166C polymorphisms and HT, we observed that DCM, DCT, and DAT haplotypes of ACE/AGT1R/AGT polymorphisms reduced the risk of HT while ICM haplotype increased it. 
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